Professor Linda-Gail Bekker, from the Desmond Tutu Health Foundation, was overwhelmed with emotion when she learned the results of a new HIV prevention drug trial conducted by Gilead. The new drug, lenacapavir, offered 100% protection against HIV for thousands of young women aged 16 to 25 in South Africa and Uganda. Bekker, who has witnessed the devastating impact of HIV…